{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:36:29Z","timestamp":1771065389197,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Dilated Cardiomyopathy (DCM) is one of the leading causes of non-ischemic cardiomyopathy in the United States (US). The aim of our study is to analyze the general trends in DCM admissions between 2016 and 2021, and analyze social and healthcare disparities in terms of treatments and outcomes. Methods: National Inpatient Sample (NIS) data for the years 2016 to 2021 were used for the analysis. General population trends were analyzed. Normality of data distribution was tested using the Kolmogorov\u2013Smirnov test and homogeneity was assessed using Levine\u2019s test. One-way ANOVA was used after confirmation of normality of distribution to analyze social and healthcare disparities. Subgroup analysis was conducted, with the paired t-test for continuous variables and Fischer\u2019s exact t-test for categorical variables to analyze statistical differences. Multivariate regression analysis was conducted to analyze the association of factors that were significant in the one-way ANOVA and paired t\/chi square tests. A two-tailed p-value &lt; 0.05 was used to determine statistical significance. Results: A total of 5262 admissions for DCM were observed between 2016 and 2021. A general declining trend was observed in the total number of DCM admissions, with a 33.51% decrease in total admissions in 2021 compared to 2016. All-cause in-hospital mortality remained stable across the years (between 3.5% and 4.5%). A total of 15.3% of admissions had CRT\/ICD devices in place. A total of 425 patients (8.07%) for DCM underwent HT, and 214 admissions for DCM (4.06%) underwent LVAD placements between 2016 and 2021 In terms of interventions for DCM, namely Cardiac Resynchronization Therapy (CRT), Left Ventricular Assist Devices (LVADs) and Heart Transplantations (HTs), significant variance was observed in the mean age of the admissions with admissions over the mean age of 55 had lower number of interventions. Significant variance in terms of sex was observed for DCM admissions receiving HT, with lower rates observed for females. In terms of quarterly income, patients belonging to the lowest fourth quartile had higher rates of LVAD and HT compared to general DCM admissions. In the multivariate regression analysis, age at admission had significant association with lower chances of receiving LVADs and HT among DCM admissions, and significant association with higher chances of all-cause mortality during the hospital stay. Conclusions: A general declining trend in the total number of DCM admissions was observed between 2016 and 2021. Significant gender disparities were seen with lower rates of females with DCM receiving LVADs and HT. DCM admissions with mean age of 55 and above were found to have significantly lower rates of receiving LVADs and HT, and higher chances of all-cause mortality during the admission.<\/jats:p>","DOI":"10.3390\/medsci13030083","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T09:24:18Z","timestamp":1750757058000},"page":"83","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["National Trends in Admissions, Treatments, and Outcomes for Dilated Cardiomyopathy (2016\u20132021)"],"prefix":"10.3390","volume":"13","author":[{"given":"Vivek Joseph","family":"Varughese","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of South Carolina-Prisma Health, Columbia, SC 29201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-7424","authenticated-orcid":false,"given":"Abdifitah","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Washington, Seattle, WA 98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vignesh Krishnan","family":"Nagesh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Atoot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the World Heart Federation","volume":"62","author":"Arbustini","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0735-1097(94)90735-8","article-title":"Prediction of improvement in recent oncet cardiomyopathy after referral for heart transplantation","volume":"23","author":"Steimle","year":"1994","journal-title":"J. Am. Coll. Cardiol"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"(1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet, 353, 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","first-page":"E895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/138161282104141204141851","article-title":"Pharmacotherapy of dilated cardiomyopathy","volume":"21","author":"Spinarova","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2015.09.023","article-title":"Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study","volume":"202","author":"Linde","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.14740\/cr1387","article-title":"Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature","volume":"13","author":"Alsamman","year":"2022","journal-title":"Cardiol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Masarone, D., Kittleson, M.M., Falco, L., Martucci, M.L., Catapano, D., Brescia, B., Petraio, A., De Feo, M., and Pacileo, G. (2023). The ABC of Heart Transplantation\u2014Part 1: Indication, Eligibility, Donor Selection, and Surgical Technique. J. Clin. Med., 12.","DOI":"10.3390\/jcm12165217"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1051","DOI":"10.1161\/CIR.0000000000001214","article-title":"Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association","volume":"149","author":"Blumer","year":"2024","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.healun.2019.05.004","article-title":"HFSA\/SAEM\/ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices","volume":"38","author":"Givertz","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","article-title":"Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: A prospective study","volume":"123","author":"Birks","year":"2011","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dandel, M. (2023). Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12206451"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.healun.2023.08.016","article-title":"Increased disparities in waitlist and post-heart transplantation outcomes according to socioeconomic status with the new heart transplant allocation system","volume":"43","author":"Kelty","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.124.070872","article-title":"Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy","volume":"151","author":"Bergan","year":"2025","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2023.11970","article-title":"Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry","volume":"330","author":"Jordan","year":"2023","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.jacc.2021.10.021","article-title":"Impact of Racial and Ethnic Disparities on Patients With Dilated Cardiomyopathy: JACC Focus Seminar 7\/9","volume":"78","author":"Ntusi","year":"2021","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/3\/83\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:59Z","timestamp":1760032619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/3\/83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medsci13030083"],"URL":"https:\/\/doi.org\/10.3390\/medsci13030083","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}